Introduction Small cell lung cancer (SCLC) can progress despite initial platinum-based chemotherapy, leaving patients with limited treatment options. The DeLLphi-304 trial evaluated tarlatamab against standard-of-care
The BELINDA trial compared a tisagenlecleucel treatment strategy with standard care in adults with aggressive B-cell non-Hodgkin lymphoma. Learn about the study design, event-free survival results, safety findings, and limitations.
Learn what the Phase 3 innovaTV 301 trial found about tisotumab vedotin for recurrent or metastatic cervical cancer in plain language.
Clear, evidence-based explanations of clinical trials, study results, and medical research—written in plain language.
